鹿児島大学大学院 医歯学総合研究科 心臓血管・高血圧内科学

X (旧Twitter)Facebook

Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University

研究について

研究:業績

【2014】原著(英文)

  • Hanaoka Y, Yasuda O, Soejima H, Miyata K, Yamamoto E, Izumiya Y, Maeda N, Ohishi M, Rakugi H, Oike Y, Kim-Mitsuyama S, Ogawa H.
  • Tissue inhibitor of metalloproteinase-3 knockout mice exhibit enhanced energy expenditure through thermogenesis.
    PLoS One 2014; 9: e94930.
  • Ben-Shlomo Y, Spears M, Boustred C, May M, Simon GA, Benjamin EJ, Boutouyrie P, Cameron J, Chen CH, Cruickshank JK, Hwang SJ, Lakatta EG, Laurent S, Maldonado J, Mitchell GF, Najjar SS, Newman AB, Ohishi M, Pannier B, Pereira T, Ramachandran VS, Shokawa T, Sutton-Tyrell K, Verbeke F, Wang KL, Webb DJ, Hansen TW, Zoungas S, McEniery CM, Cockcroft JR, Wilkinson IB.
  • Aortic pulse wave velocity improves cardiovascular event prediction: an individual participant meta-analysis of prospective observational data from 17,635 subjects.
    J Am Coll Cardiol 2014; 63: 636-646.
  • Wang X, Sugimoto K, Fujisawa T, Shindo N, Minato S, Kamada Y, Hamano M, Ohishi M, Ikegami H, Rakugi H.
  • Novel effect of ezetimibe to inhibit the development of non-alcoholic fatty liver disease in Fatty Liver Shionogi mouse.
    Hepatol Res 2014; 44: 102-113.
  • Natsuaki M, Morimoto T, Furukawa Y, Nakagawa Y, Kadota K, Yamaji K, Ando K, Shizuta S, Shiomi H, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Tamura T, Shirotani M, Miki S, Matsuda M, Takahashi M, Ishii K, Tanaka M, Aoyama T, Doi O, Hattori R, Kato M, Suwa S, Takizawa A, Takatsu Y, Shinoda E, Eizawa H, Takeda T, Lee JD, Inoko M, Ogawa H, Hamasaki S, Horie M, Nohara R, Kambara H, Fujiwara H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto PCI/CABG registry cohort-2 investigators.
  • Late adverse events after implantation of sirolimus-eluting stent and bare-metal stent: long-term (5-7 years) follow-up of the Coronary Revascularization Demonstrating Outcome study-Kyoto registry Cohort-2.
    Circ Cardiovasc Interv 2014; 7: 168-79.
  • Goto K, Nakai K, Shizuta S, Morimoto T, Shiomi H, Natsuaki M, Yahata M, Ota C, Ono K, Makiyama T, Nakagawa Y, Furukawa Y, Kadota K, Takatsu Y, Tamura T, Takizawa A, Inada T, Doi O, Nohara R, Matsuda M, Takeda T, Kato M, Shirotani M, Eizawa H, Ishii K, Lee JD, Takahashi M, Horie M, Takahashi M, Miki S, Aoyama T, Suwa S, Hamasaki S, Ogawa H, Mitsudo K, Nobuyoshi M, Kita T, Kimura T; CREDO-Kyoto Registry Cohort-2 Investigators.
  • Anticoagulant and antiplatelet therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    Am J Cardiol 2014; 114: 70-8.
  • Kohjitani A, Miyata M, Iwase Y, Ohno S, Tohya A, Manabe Y, Hashiguchi T, Sugiyama K.
  • Associations between the autonomic nervous system and the second derivative of the finger photoplethysmogram indices.
    J Atheroscler Thromb 2014; 21: 501-8.
  • Shimokawahara H, Jougasaki M, Setoguchi M, Ichiki T, Sonoda M, Nuruki N, Nakashima H, Murohara T, Tsubouchi H.
  • Relationship between vascular endothelial growth factor and left ventricular dimension in patients with acute myocardial infarction.
    Journal of Cardioligy 2014; 64: 360-5.
  • Lee A, Jeong D, Mitsuyama S, Oh JG, Liang L, Ikeda Y, Sadoshima J, Hajjar R, Kho C.
  • The Role of SUMO-1 in Cardiac Oxidative Stress and Hypertrophy.
    Antioxid Redox Signal 2014; 21: 1986-2001.
  • Yamamoto T, Byun J, Zhai P, Ikeda Y, Oka S, Sadoshima J.
  • Nicotinamide mononucleotide, an intermediate of NAD+ synthesis, protects the heart from ischemia and reperfusion.
    PLoS One 2014; 9: e98972.
  • Ichiki T, Schirger JA, Huntley BK, Brozovich FC, Maleszewski JJ, Sandberg SM, Sangaralingham SJ, Park SJ, and Burnett JC, Jr.
  • Cardiac Fibrosis in End-Stage Heart Failure and the Cardiac Natriuretic Peptide Guanylyl Cyclase System: Regulation and Therapeutic Implications.
    J Mol Cell Cardiol 2014; 75: 199-205.
  • Yoshino S, Cilluffo R, Best PJ, Atkinson EJ, Aoki T, Cunningham JM, de Andrade M, Choi BJ, Lerman LO, Lerman A.
  • Single nucleotide polymorphisms associated with abnormal coronary microvascular function.
    Coron Artery Dis 2014; 25: 281-9.
  • McKie PM, Cataliotti A, Ichiki T, Sangaralingham SJ, Chen HH, Burnett, JC, Jr.
  • M-Atrial Natriuretic Peptide and Nitroglycerin in Experimental Acute Hypertensive Heart Failure: Differential Actions of Two cGMP Activating Therapeutics.
    J Am Heart Assoc 2014; 3: e000206.
  • Yoshino S, Cassar A, Matsuo Y, Herrmann J, Gulati R, Prasad A, Lennon RJ, Lerman LO, Lerman A.
  • Fractional flow reserve with dobutamine challenge and coronary microvascular endothelial dysfunction in symptomatic myocardial bridging.
    Circ J 2014; 78: 685-92.
  • Kajiya T.
  • Clinical benefits of azilsartan beyond blood pressure lowering?
    Cardiovasc Drugs Ther 2014; 28: 293-294.
  • Kajiya T, Yamashita M, Otsuji H, Toyonaga K, Lee S.
  • Assessment of coronary collateral artery by CT angiography in patients with ST-elevation acute myocardial infarction.
    Int J Cardiol 2014; 176: 1359-61.
  • Imai M, Kimura T, Morimoto T, Saito N, Shiomi H, Kawaguchi R, Kan H, Mukawa H, Fujita H, Ishise T, Hayashi F, Nagao K, Take S, Taniguchi H, Sakamoto H, Yamane T, Shirota K, Tamekiyo H, Okamura T, Kishi K, Miyazaki S, Yamamoto S, Yamaji K, Kawasaki T, Taguchi E, Nakajima H, Kosedo I, Tada T, Kadota K, Mitsudo K.
  • Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy.
    Cardiovasc Interv Ther 2014; 29: 226-36.
  • Tokushige A, Shiomi H, Morimoto T, Ono K, Furukawa Y, Nakagawa Y, Kadota K, Ando K, Shizuta S, Tada T, Tazaki J, Kato Y, Hayano M, Abe M, Hamasaki S, Ohishi M, Nakashima H, Mitsudo K, Nobuyoshi M, Kita T, Imoto Y, Sakata R, Okabayashi H, Hanyu M, Shimamoto M, Nishiwaki N, Komiya T, Kimura T; CREDO-Kyoto PCI/CABG Registry Cohort-2 Investigators.
  • Incidence and outcome of surgical procedures after coronary artery bypass grafting compared with those after percutaneous coronary intervention: a report from the Coronary Revascularization Demonstrating Outcome Study in Kyoto PCI/CABG Registry Cohort-2.
    Circ Cardiovasc Interv 2014; 7: 482-91.
  • Higo K, Kubota K, Takeda A, Higashi M, Ohishi M.
  • Successful Antemortem Diagnosis and Treatment of Pulmonary Tumor Thrombotic Microangiopathy.
    Intern Med 2014; 53: 2595-9.
  • Cheng KK, Akasaki Y, Lecommandeur E, Lindsay RT, Murfitt S, Walsh K, Griffin JL.
  • Metabolomic analysis of Akt1-mediated muscle hypertrophy in models of diet-induced obesity and age-related fat accumulation.
    J. Proteome Res (Epub ahead of print)
  • Kawai T, Ohishi M, Onishi M, Ito N, Takeya Y, Oguro R, Takami Y, Yamamoto K, Rakugi H.
  • Prognostic impact of regional arterial stiffness in hypertensive patients.
    Heart Vessels (in press)
  • Ikeda Y, Shirakabe A, Maejima Y, Zhai P, Sciarretta S, Toli J, Nomura M, Mihara K, Egashira K, Ohishi M, Abdellatif M, Sadoshima J.
  • Endogenous Drp1 Mediates Mitochondrial Autophagy and Protects the Heart Against Energy Stress.
    Circ Res 2014 (in press)
  • Ikeda Y, Shirakabe A, Brady C, Zablocki D, Ohishi M, Sadoshima J.
  • Molecular Mechanisms Mediating Mitochondrial Dynamics and Mitophagy and their Functional Roles in the Cardiovascular System.
    J Mol Cell Cardiol 2014 (in press)
  • Ikeda Y, Sciarretta S, Nagarajan N, Rubattu S, Volpe M, Frati G, Sadoshima J.
  • New Insights into the Role of Mitochondrial Dynamics and Autophagy during Oxidative Stress and Aging in the Heart.
    Oxidative Medicine and Cellular Longevity 2014 (in press)
  • Huntley BK, Sandberg SM, Heublein DM, Sangaralingham SJ, Burnett JC, Jr, and Ichiki T.
  • ProBNP1-108 Processing and Degradation in Human Heart Failure.
    Circ HF 2014 (in press)
  • Kajiya T, Tan HC, Low AF.
  • Successful slender percutaneous coronary intervention (PCI) with ABSORB bioresorbable vascular scaffold (BVS).
    Int J Cardiol 2014 (in press)
  • Maemura R, Kajiya T, Koriyama N, Lee S.
  • Heart failure caused by atrial fibrillation in a patient with isolated adrenocorticotropic hormone (ACTH) deficiency and Hashimoto’s thyroiditis.
    Heart Views 2014 (in press)
  • Liang M, Kajiya T, Tan HC.
  • High Grade Culprit Lesions are a Common Cause of ST-segment Elevation Myocardial Infarction.
    Singapore Med J 2014 (in press)
  • Namino F, Iriki Y, Maenosono R, Ichiki H, Okui H, Yoshimura A, Oketani N, Matsushita M, Ohishi M, Hashiguchi T.
  • The Optimal Setting of Complex Fractionated Atrial Electrograms Software in Substrate Ablation for Atrial Fibrillation.
    J arrhythmia 2014 (in press)
  • 昨年度追加分
  • Akasaki Y, Ouchi N, Izumiya Y, Bernardo BL, Lebrasseur NK, Walsh K.
  • Glycolytic fast-twitch muscle fiber restoration counters adverse age-related changes in body composition and metabolism.
    Aging Cell 2014; 13: 80-91.